Nasdaq:US$18.99 (+0.58) | HKEX:HK$30.35 (+0.00) | AIM:£3.03 (-0.01)
Search Result
Previous Article   |   Next Article
公告及新聞稿, 腫瘤學 / 免疫學 | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China